HK1 haemolytic anaemia in association with a neurological phenotype and co-existing CEP290 Meckel-Gruber in a Romani family

Erina Sasaki,Ethna Phelan,Mary O'Regan,Abdul Halim Kassim,Jan Miletin,Corrina McMahon,Maureen J O'Sullivan,Julia Baptista,Sally Ann Lynch

DOI: https://doi.org/10.1111/cge.14058

Abstract:HK1 deficient Haemolytic Anaemia in association with a Neurological Phenotype & co-existing Meckel-Gruber due to CEP290 in a Romani family.

What problem does this paper attempt to address?

De novo variants in HK1 associated with neurodevelopmental abnormalities and visual impairment

Volkan Okur,Megan T. Cho,Richard van Wijk,Brigitte van Oirschot,Jonathan Picker,Stephanie A. Coury,Dorothy Grange,Linda Manwaring,Ian Krantz,Colleen Clark Muraresku,Peter J. Hulick,Holley May,Eric Pierce,Emily Place,Kinga Bujakowska,Aida Telegrafi,Ganka Douglas,Kristin G. Monaghan,Amber Begtrup,Ashley Wilson,Kyle Retterer,Kwame Anyane-Yeboa,Wendy K. Chung

DOI: https://doi.org/10.1038/s41431-019-0366-9

2019-02-18

European Journal of Human Genetics

Abstract:Hexokinase 1 (HK1) phosphorylates glucose to glucose-6-phosphate, the first rate-limiting step in glycolysis. Homozygous and heterozygous variants in HK1 have been shown to cause autosomal recessive non-spherocytic hemolytic anemia, autosomal recessive Russe type hereditary motor and sensory neuropathy, and autosomal dominant retinitis pigmentosa (adRP). We report seven patients from six unrelated families with a neurodevelopmental disorder associated with developmental delay, intellectual disability, structural brain abnormality, and visual impairments in whom we identified four novel, de novo missense variants in the N-terminal half of HK1. Hexokinase activity in red blood cells of two patients was normal, suggesting that the disease mechanism is not due to loss of hexokinase enzymatic activity.

genetics & heredity,biochemistry & molecular biology
Novel KRIT1/CCM1 and MGC4607/CCM2 Gene Variants in Chinese Families with Cerebral Cavernous Malformations

Kang Wang,Dengchang Wu,Baorong Zhang,Guohua Zhao

DOI: https://doi.org/10.3389/fneur.2018.01128

IF: 3.4

2018-01-01

Frontiers in Neurology

Abstract:Familial cerebral cavernous malformations (CCMs) are autosomal dominant disorders characterized by hemorrhagic strokes, recurrent headache, epilepsy, and focal neurological deficits. Genetic variants in KRIT1/CCM1, MGC4607/CCM2, and PDCD10/CCM3 genes contribute to CCMs. The clinical information of two Chinese families with CCMs was collected. MRI and video-electroencephalography were performed. Genetic variants of CCM1, CCM2, and CCM3 genes were investigated by exome sequencing. The patients were presented with recurrent epilepsy or headache. Susceptibility-weighted images of brains showed many dark dots, while video-electroencephalography revealed many spikes from multiple brain regions of patients. Exome sequencing revealed a novel CCM1 genetic variant (c.1599_1601TGAdel, p.Asp533del) and a novel CCM2 genetic variant (c.773delA, p.K258fsX34) in Family one and Family two, respectively; cosegregation existed in these two families. The two family members presented typical CCMs symptoms. These two novel genetic variants in CCM1 and CCM2 genes were the causation of CCM in the two Chinese families, and our data enriched the genetic variant spectrum of CCM genes.
Molecular characterization of six new cases of red blood cell hexokinase deficiency yields four novel mutations in HK1

Pavla Koralkova,Renata Mojzikova,Brigitte van Oirschot,Christine Macartney,Pavel Timr,Joan Lluis Vives Corrons,Zuzana Striezencova Laluhova,Katerina Lejhancova,Vladimir Divoky,Richard van Wijk

DOI: https://doi.org/10.1016/j.bcmd.2016.04.002

Abstract:Hexokinase (HK) is a key enzyme of glycolysis, the only metabolic pathway able to provide the red blood cell with ATP. HK deficiency is a very rare hereditary disorder with severe chronic nonspherocytic hemolytic anemia (HNSHA) as a major clinical feature. To date, only 24 patients with HK deficiency have been identified. Here, we report the molecular analysis of six new cases of HK deficiency. A total of six different mutations were detected in HK1, four of them described here for the first time: c.2599C>T p.(His867Tyr), c.1799C>T p.(Thr600Met), c.873-2A>G and c.493-1G>A. The pathogenic nature of the identified missense mutations was confirmed by biochemical and 3-dimensional structural analysis. The effects of the novel splice site mutation c.873-2A>G were studied at the level of pre-mRNA processing, and confirmed at the protein level. All together, these results provide a better insight into the pathogenesis of this rare red cell disorder, and contribute to a better understanding of the genotype-phenotype correlation in HK deficiency.
De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias (vol 103, Pg 666, 2018)

Katherine L. Helbig,Robert J. Lauerer,Jacqueline C Bahr,Ivana A. Souza,Candace T. Myers,Betül Börkü Uysal,Niklas Schwarz,María A. Gandini,Sun Huang,Boris Keren,Cyril Mignot,Alexandra Afenjar,Thierry Billette de Villemeur,Delphine Héron,Caroline Nava,Stéphanie Valence,Julien Buratti,Christina Fagerberg,Kristina P. Soerensen,Maria Kibæk,Erik‐Jan Kamsteeg,David A. Koolen,Boudewijn Gunning,Helenius J. Schelhaas,Michael C. Kruer,Jordana Fox,Somayeh Bakhtiari,Randa Jarrar,Sergio Padilla-López,Kristin Lindstrom,Sheng Jin,Xue Zeng,Kaya Bilgüvar,Antigone Papavasileiou,Qinghe Xing,Changlian Zhu,Katja Boysen,Filippo Pinto e Vairo,Brendan C. Lanpher,Eric W. Klee,Jan‐Mendelt Tillema,Eric T. Payne,Margot A. Cousin,Teresa Kruisselbrink,Myra J. Wick,Joshua Baker,Eric Haan,Nicholas J. Smith,Azita Sadeghpour,Erica E. Davis,Nicholas Katsanis,Mark Corbett,Alastair H. MacLennan,Jozef Gécz,Saskia Biskup,Eva Goldmann,Lance H. Rodan,Elizabeth Kichula,Eric Segal,Kelly E. Jackson,Alexander Asamoah,David Dimmock,Julie McCarrier,Lorenzo D. Botto,Francis Filloux,Tatiana Tvrdik,Gregory D. Cascino,Sherry Klingerman,Catherine M. Neumann,Raymond Wang,Jessie C. Jacobsen,Melinda Nolan,Russell G. Snell,Klaus Lehnert,Lynette G. Sadleir,Britt‐Marie Anderlid,Malin Kvarnung,Renzo Guerrini,Michael J. Friez,Michael J. Lyons,Jennifer Leonhard,Gabriel Kringlen,Kari Casas,Christelle Moufawad El Achkar,Lacey Smith,Alexander Rotenberg,Annapurna Poduri,Alba Sanchis-Juan,Keren Carss,Julia Rankin,Adam Zeman,F. Lucy Raymond,Moira Blyth,Bronwyn Kerr,Karla Ruiz,Jill E. Urquhart,Imelda Hughes,Siddharth Banka,Ulrike B. S. Hedrich,Ingrid E. Scheffer,Ingo Helbig,Gerald W. Zamponi,Holger Lerche,Heather C. Mefford

2019-01-01

Abstract:(The American Journal of Human Genetics 103, 666–678; November 1, 2018) In the version of this article originally published online, Qinghe Xing's name was misspelled as Qinghe Xin. Also, Azita Sadeghpour, Erica E. Davis, and Nicholas Katsanis (all at Center for Human Disease Modeling, Duke University Medical Center, Durham, NC 27701, USA) and the Task Force for Neonatal Genomics were omitted from the author list. The members of the Task Force for Neonatal Genomics are as follows: Alexander Allori, Misha Angrist, Patricia Ashley, Margarita Bidegain, Brita Boyd, Eileen Chambers, Heidi Cope, C. Michael Cotten, Theresa Curington, Erica E. Davis, Sarah Ellestad, Kimberley Fisher, Amanda French, William Gallentine, Ronald Goldberg, Kevin Hill, Sujay Kansagra, Nicholas Katsanis, Sara Katsanis, Joanne Kurtzberg, Jeffrey Marcus, Marie McDonald, Mohammed Mikati, Stephen Miller, Amy Murtha, Yezmin Perilla, Carolyn Pizoli, Todd Purves, Sherry Ross, Azita Sadeghpour, Edward Smith, and John Wiener. The authors apologize for these omissions.
Persistent Hyperplastic Primary Vitreous with Microphthalmia and Coloboma in a Patient with Okur-Chung Neurodevelopmental Syndrome

Hiroaki Murakami,Tomoko Uehara,Yumi Enomoto,Naoto Nishimura,Tatsuro Kumaki,Yukiko Kuroda,Mizuki Asano,Noriko Aida,Kenjiro Kosaki,Kenji Kurosawa

DOI: https://doi.org/10.1159/000517977

Abstract:Okur-Chung neurodevelopmental syndrome is a rare autosomal dominant disorder caused by pathogenic variants in CSNK2A1, which encodes the alpha 1 catalytic subunit of -casein kinase II. This syndrome is characterized by intellectual disability, developmental delay, and multisystemic -abnormalities including those of the brain, extremities, and skin as well as cardiovascular, gastrointestinal, and immune systems. In this study, we describe a 5-year-old boy with a de novo novel nonsense variant in CSNK2A1, NM_001895.3:c.319C>T (p.Arg107*). He showed bilateral persistent hyperplastic primary vitreous with microphthalmia, lens dysplasia, and coloboma. Ocular manifestations are very rare in this syndrome, and this study expands the spectrum of the clinical presentations of this syndrome.
The neurological core features of the infantile‐onset multisystem neurologic, endocrine, and pancreatic disease: A novel nonsense mutation in an Italian family

Alessia Mammi,Alessandro Geroldi,Serena Patrone,Fabio Gotta,Paola Origone,Andrea Gaudio,Andrea La Barbera,Francesca Sanguineri,Clarissa Ponti,Michele Iacomino,Monica Traverso,Edoardo Ferlazzo,Angelo Schenone,Angelo Pascarella,Oreste Marsico,Paola Mandich,Emilia Bellone

DOI: https://doi.org/10.1111/jns.12636

IF: 5.188

2024-06-16

Journal of the Peripheral Nervous System

Abstract:Aim Biallelic mutations in the PTRH2 gene have been associated with infantile multisystem neurological, endocrine, and pancreatic disease (IMNEPD), a rare autosomal recessive disorder of variable expressivity characterized by global developmental delay, intellectual disability or borderline IQ level, sensorineural hearing loss, ataxia, and pancreatic insufficiency. Various additional features may be included, such as peripheral neuropathy, facial dysmorphism, hypothyroidism, hepatic fibrosis, postnatal microcephaly, cerebellar atrophy, and epilepsy. Here, we report the first Italian family presenting only predominant neurological features. Methods Extensive neurological and neurophysiological evaluations have been conducted on the two affected brothers and their healthy mother since 1996. The diagnosis of peripheral neuropathy of probable hereditary origin was confirmed through a sural nerve biopsy. Exome sequencing was performed after the analysis of major neuropathy‐associated genes yielded negative results. Results Whole‐exome sequencing analysis identified the homozygous substitution c.256C>T (p.Gln86Ter) in the PTRH2 gene in the two siblings. According to American College of Medical Genetics and Genomics (ACMG) guidelines, the variant has been classified as pathogenic. At 48 years old, the proband's reevaluation confirmed a demyelinating sensorimotor polyneuropathy with bilateral sensorineural hearing loss that had been noted since he was 13. Additionally, drug‐resistant epileptic seizures occurred when he was 32 years old. No hepatic or endocrinological signs developed. The younger affected brother, 47 years old, has an overlapping clinical presentation without epilepsy. Interpretation Our findings expand the clinical phenotype and further demonstrate the clinical heterogeneity related to PTRH2 variants. We thereby hope to better define IMNEPD and facilitate the identification and diagnosis of this novel disease entity.

neurosciences,clinical neurology
Identification of Pathogenic Variants in RPGRIP1L with Meckel Syndrome and Preimplantation Genetic Testing in a Chinese Family

Zhang Ping,Wu Bingbing,Wang Yaqiong,Ren Yunyun,Li Gang,Qan Yanyan,Lei Caixia,Wang Huijun

DOI: https://doi.org/10.1007/s43032-022-00898-y

2022-01-01

Reproductive Sciences

Abstract:Meckel syndrome (MKS, OMIM:249000) is a severe multiorgan dysplastic lethal ciliopathy with extreme genetic heterogeneity. Defects in RPGRIP1L are the cause of MKS type 5 (MKS5, OMIM:611561). However, only six different variants have been reported in eight MKS5 cases with biallelic variants. Here, we describe the case of a Chinese family with recurrent fetal malformations. The proband was a 14-week gestation fetus with occipital encephalocele, polycystic kidneys, polydactyly, and single ventricular heart. Trio whole-exome sequencing was performed, and two novel compound heterozygous variants of RPGRIP1L (c.427C > T, p.Gln143Ter and c.1351-11A > G) were identified. cDNA studies of the splicing variant demonstrated a reading-frame shift with a subsequent premature stop codon (p.Glu451Serfs*6). After the proband was diagnosed with MKS5, the couple chose preimplantation genetic testing for monogenic disorders (PGT-M) and prenatal genetic diagnosis (PND) to prevent the transmission of pathogenic variants, which led to a successful pregnancy recently. In summary, we have identified two novel variants of RPGRIP1L in a Chinese family, which expand the variant spectrum of MKS5. Furthermore, we have described the successful application of PGT-M and PND in this family. These techniques could assist couples with a genetic predisposition in avoiding the transmission of genetic diseases to their offspring.
Novel and recurrent PHGDH and PSAT1 mutations in Chinese patients with Neu-Laxova syndrome

Cheng Ni,Ru-Hong Cheng,Jia Zhang,Jian-Ying Liang,Ru-Qu Wei,Ming Li,Zhi-Rong Yao

DOI: https://doi.org/10.1684/ejd.2019.3673

2019-12-01

Abstract:Background: Neu-Laxova syndrome (NLS) is a rare hereditary disorder featuring intrauterine growth retardation, remarkable oedema with skin restriction, limb contracture, ichthyosis, and craniofacial anomaly. NLS shares multiple overlapping characteristics with several other inheritable refractory diseases: for example, harlequin foetus and restrictive dermopathy. To date, many NLS patients have been described, although the number of NLS cases with clear genetic aetiology remains limited. Objectives: To characterize the clinical and genetic features of NLS in two Chinese families. Materials and methods: Relevant skin tissue samples, blood specimens, and follow-up data from two unrelated Chinese families with perinatal fatal disorders were collected. To obtain a definitive diagnosis, six genes (ABCA12, LMNA, ZMPSTE24, PHGDH, PSAT1 and PSPH), previously implicated in the pathogenesis of inheritable refractory diseases with similar phenotypic expression to that of the affected members in the two pedigrees, were sequenced. We also performed tandem mass spectrometry, structural protein modelling, and immunohistochemical analysis to further support the genetic findings. Results: New and recurrent missense mutations were identified in two genes (PHGDH and PSAT1) associated with NLS, which further supports the recent findings that NLS is genetically heterogeneous and could result from mutations in genes encoding enzymes of the L-serine biosynthesis pathway. Structural changes in PHGDH and PSAT1 proteins were revealed by molecular modelling. Finally, a tandem mass spectrometry assay and immunohistochemical analysis further corroborated the diagnosis of NLS. Conclusion: This study is the first description of PHGDH and PSAT1 mutations in Chinese NLS patients, which strongly implicates them in the pathogenesis of NLS.
Case Report: A rare form of congenital erythrocytosis due to SLC30A10 biallelic variants—differential diagnosis and recommendation for biochemical and genetic screening

Rosalinda Giannini,Emanuele Agolini,Giuseppe Palumbo,Antonio Novelli,Giacomo Garone,Melissa Grasso,Giovanna Stefania Colafati,Marta Matraxia,Eleonora Piccirilli,Annalisa Deodati,Giulia Ceglie

DOI: https://doi.org/10.3389/fped.2024.1319885

IF: 3.569

2024-01-13

Frontiers in Pediatrics

Abstract:Congenital erythrocytosis recognizes heterogeneous genetic basis and despite the use of NGS technologies, more than 50% of cases are still classified as idiopathic. Herein, we describe the case of a 3-year-old boy with a rare metabolic disorder due to SLC30A10 bi-allelic mutations and characterized by hypermanganesemia, congenital erythrocytosis and neurodegeneration, also known as hypermanganesemia with dystonia 1 (HMNDYT1). The patient was treated with iron supplementation and chelation therapy with CaNa2EDTA, resulting in a significative reduction of blood manganese levels and erythrocytosis indexes. Although it couldn't be excluded that the patient's developmental impairment was part of the phenotypic spectrum of the disease, after three months from starting treatment no characteristic extrapyramidal sign was detectable. Our findings suggest the importance of assessing serum manganese levels in patients with unexplained polycythemia and increased liver enzymes. Moreover, we highlight the importance of extended genetic testing as a powerful diagnostic tool to uncover rare genetic forms of congenital erythrocytosis. In the described patient, identifying the molecular cause of erythrocytosis has proven essential for proper clinical management and access to therapeutic options.

pediatrics
Refractory and Fatal Presentation of Severe Autoimmune Hemolytic Anemia in a Child With the DNASE1L3 Mutation Complicated With an Additional DOCK8 Variant

Aysenur Paç Kisaarslan,Maximilam Witzel,Ekrem Unal,Meino Rohlfs,Başaknur Akyildiz,Muhammet E Dogan,Hakan Poyrazoglu,Christoph Klein,Turkan Patiroglu

DOI: https://doi.org/10.1097/MPH.0000000000001780

2021-04-01

Abstract:Various autoimmune diseases may be associated with primary immune deficiencies. We reported a case with a loss-of-function mutation in DNASE1L3, a gene described previously in families with systemic lupus erythematosus. In addition, the patient showed a novel homozygous missense variant in DOCK8, a gene known to be responsible for the hyper-IgE recurrent infection syndrome (HIES). A 3-year-old girl born to consanguine parents presented with chronic urticarial rash, hemolytic anemia, pulmonary hemorrhage, and hypovolemic shock findings. She had a low hemoglobin level, a positive direct antiglobulin test, antinuclear antibody and anti-double stranded DNA, low C3 and C4, third-degree tricuspid regurgitation, and severe enlargement of the right ventricle on echocardiography, suggesting pulmonary embolism. Despite treatment with intravenous immunoglobulin, pulse metilprednisolone, rituximab, and supportive treatment for shock, the patient died on the seventh day. Whole-exome sequencing indicated a homozygous stop variant c.537G>A (p. Trp179Ter) in DNASE1L3. In addition, a possibly pathogenic homozygous missense variant in the HIES gene DOCK8 was detected. The occurrence of potentially clinically relevant, genetic variants in several genes posed various challenges with respect to diagnosis, treatment, and prognosis.
Two novel variants in CEP152 caused Seckel syndrome 5 in a Chinese family

Li Zhang,Yanling Teng,Haoran Hu,Huimin Zhu,Juan Wen,Desheng Liang,Zhuo Li,Lingqian Wu

DOI: https://doi.org/10.3389/fgene.2022.1052915

IF: 3.7

2023-01-05

Frontiers in Genetics

Abstract:Background: Seckel syndrome (SCKL) is a rare autosomal recessive inherited disorder, which is mainly characterized by intrauterine and postnatal growth restrictions, microcephaly, intellectual disability, and a typical "bird-head" facial appearance. Here, we aimed to identify the genetic etiology of a family with suspected SCKL. Methods: This study enrolled a Chinese family suspected of SCKL with their detailed family history and clinical data. We performed karyotype analysis, copy number variation sequencing (CNV-seq), and trio whole-exome sequencing (WES) to explore the genetic etiology in the proband. Furthermore, the quantitative real-time polymerase chain reaction (PCR) and reverse transcription-PCR (RT-PCR) were conducted to confirm the pathogenicity of novel variants. Results: The karyotype analysis and CNV-seq were normal in the proband. Two novel variants in CEP152 , c.1060C>T (p.Arg354*) and c.1414-14A>G, were identified in the proband through trio-WES. The qPCR results showed that the total CEP152 mRNA expression levels were significantly reduced in c.1060C>T (p.Arg354*) and c.1414-14A>G compared with healthy control individuals. Moreover, aberrant skipping of exon 12 due to the non-canonical splice-site variant was revealed by RT-PCR and Sanger sequencing. Conclusion: Our findings expanded pathogenic variant spectra in SCKL and offered new insights into the pathogenicity of a non-classical splice-site variant in CEP152 , which provided additional information for helping the family improve pregnancy plans in the future.

genetics & heredity
Molecularly confirmed pontocerebellar hypoplasia in a large family from Slovakia with four severely affected children

Eva Radvanska,Zuzana Pos,Andrea Zatkova,Michaela Hyblova,Frantisek Bauer,Tomas Szemes,Ludevit Kadasi,Jan Radvanszky

DOI: https://doi.org/10.4149/BLL_2022_090

Abstract:Background: Pontocerebellar hypoplasia type 1 (PCH1) is characterized by a central and peripheral motor dysfunction associated with anterior horn cell degeneration, similar to spinal muscular atrophy (SMA). Objectives: We analysed three probands (later discovered to be siblings) suspected to have severe SMA, however, not confirmed by genetic test. Methods: Clinical-exome analysis (Illumina) was performed to identify causative variants, followed by Sanger sequencing confirmation in probands and other 10 family members. Results: Homozygous pathogenic variant c.92G>C (p.(Gly31Ala)) in the Exosome Component 3 (EXOSC3) gene was found in all 3 probands, thus confirming the diagnosis of a severe form of PCH1B. The parents and six siblings were carriers, while one sibling was homozygous for a reference allele. This variant is frequent in the Czech Roma population, where it is considered a founder mutation. Haplotype analysis in this largest reported PCH1B family showed that our patients inherited from their father (of Roma origin) a haplotype identical to that found in the Czech Roma population, thus indicating these alleles have a common origin. Conclusion: This EXOSC3 variant is rare among the general population but most likely frequent also among Roma people in Slovakia. PCH1B should be considered for a differential diagnosis in infants manifesting SMA-like phenotype, especially if of Roma origin (Tab. 1, Fig. 1, Ref. 22). Text in PDF www.elis.sk Keywords: pontocerebellar hypoplasia, PCH1B, EXOSC3, SMA plus syndromes, pathogenic sequence variant.
Comprehensive analysis of Novel mutations in CCM1/KRIT1 and CCM2/MGC4607 and their clinical implications in Cerebral Cavernous malformations

Gustavo Galvão,Luisa Menezes Trefilio,Andreza Lemos Salvio,Elielson Veloso,Soniza Vieira Alves-Leon,Fabrícia Lima Fontes-Dantas,Jorge Marcondes de Souza

DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.107947

IF: 2.677

2024-09-03

Journal of Stroke and Cerebrovascular Diseases

Abstract:Background Cerebral Cavernous Malformations (CCM) is a genetic disease characterized by vascular abnormalities in the brain and spinal cord, affecting 0.4-0.5 % of the population. We identified two novel pathogenic mutations, CCM1/KRIT1 c.811delT (p.Trp271GlyfsTer5) and CCM2/MGC4607 c.613_614insGG p.Glu205GlyfsTer31), which disrupt crucial protein domains and potentially alter disease progression. Objective The study aims to comprehensively analyze a Brazilian cohort of CCM patients, integrating genetic, clinical, and structural aspects. Specifically, we sought to identify novel mutations within the CCM complex, and explore their potential impact on disease progression. Methods We conducted a detailed examination of neuroradiological and clinical features in both symptomatic and asymptomatic CCM patients, performing genetic analyses through sequencing of the CCM1/KRIT1, CCM2/MGC4607 , and CCM3/PDCD10 genes In silico structural predictions were carried out using PolyPhen-2, SIFT, and Human Genomics Community tools. Protein-protein interactions and docking analyses were explored using the STRING database. Results Genetic analysis identifies 6 pathogenic mutations, 4 likely pathogenic, 1 variants of uncertain significance, and 7 unclassified mutations, including the novel mutations in CCM1 c.811delT and CCM2 c.613_614insGG. In silico structural analysis revealed significant alterations in protein structure, supporting their pathogenicity. Protein-protein interaction analysis indicated nuanced impacts on cellular processes. Clinically, we observed a broad spectrum of symptoms, including seizures and focal neurological deficits. However, no statistically significant differences were found in lesion burden, age of first symptom onset, or sex between the identified CCM1/KRIT1 and CCM2/MGC4607 mutations among all patients studied. Conclusion This study enhances the understanding of CCM by linking clinical variability, genetic mutations, and structural effects. The identification of these novel mutations opens new avenues for research and potential therapeutic strategies.

neurosciences,peripheral vascular disease
Frameshift mutations at the C-terminus of HIST1H1E result in a specific DNA hypomethylation signature

Andrea Ciolfi,Erfan Aref-Eshghi,Simone Pizzi,Lucia Pedace,Evelina Miele,Jennifer Kerkhof,Elisabetta Flex,Simone Martinelli,Francesca Clementina Radio,Claudia A. L. Ruivenkamp,Gijs W. E. Santen,Emilia Bijlsma,Daniela Barge-Schaapveld,Katrin Ounap,Victoria Mok Siu,R. Frank Kooy,Bruno Dallapiccola,Bekim Sadikovic,Marco Tartaglia

DOI: https://doi.org/10.1186/s13148-019-0804-0

2020-01-07

Clinical Epigenetics

Abstract:Abstract Background We previously associated HIST1H1E mutations causing Rahman syndrome with a specific genome-wide methylation pattern. Results Methylome analysis from peripheral blood samples of six affected subjects led us to identify a specific hypomethylated profile. This “episignature” was enriched for genes involved in neuronal system development and function. A computational classifier yielded full sensitivity and specificity in detecting subjects with Rahman syndrome. Applying this model to a cohort of undiagnosed probands allowed us to reach diagnosis in one subject. Conclusions We demonstrate an epigenetic signature in subjects with Rahman syndrome that can be used to reach molecular diagnosis.

oncology,genetics & heredity
Patient with a heterozygous pathogenic variant in CSNK2A1 gene: A new case to update the Okur–Chung neurodevelopmental syndrome

Albin Blanc,Céline Bonnet,Marion Wandzel,Virginie Roth,Yannis Duffourd,Hanna Safraou,Bruno Leheup,Florence Muller,Julie D Colne,François Feillet,Emmanuelle Schmitt,Matheus Castro,Jullian Savatt,Adriano Burcheri,Christophe Nemos,Christophe Philippe,Laëtitia Lambert

DOI: https://doi.org/10.1002/ajmg.a.63642

2024-05-07

American Journal of Medical Genetics Part A

Abstract:The autosomal dominant Okur–Chung neurodevelopmental syndrome (OCNDS: OMIM #617062) is a rare neurodevelopmental disorder first described in 2016. Features include developmental delay (DD), intellectual disability (ID), behavioral problems, hypotonia, language deficits, congenital heart abnormalities, and non‐specific dysmorphic facial features. OCNDS is caused by heterozygous pathogenic variants in CSNK2A1 (OMIM *115440; NM_177559.3). To date, 160 patients have been diagnosed worldwide. The number will likely increase due to the growing use of exome sequencing (ES) and genome sequencing (GS). Here, we describe a novel OCNDS patient carrying a CSNK2A1 variant (NM_177559.3:c.140G>A; NP_808227.1:p.Arg47Gln). Phenotypically, he presented with DD, ID, generalized hypotonia, speech delay, short stature, microcephaly, and dysmorphic features such as low‐set ears, hypertelorism, thin upper lip, and a round face. The patient showed several signs not yet described that may extend the phenotypic spectrum of OCNDS. These include prenatal bilateral clubfeet, exotropia, and peg lateral incisors. However, unlike the majority of descriptions, he did not present sleep disturbance, seizures or gait difficulties. A literature review shows phenotypic heterogeneity for OCNDS, whether these patients have the same variant or not. This case report is an opportunity to refine the phenotype of this syndrome and raise the question of the genotype–phenotype correlation.

genetics & heredity
A novel homozygous variant in SLC25A46 gene associated with pontocerebellar hypoplasia type 1E: a case report

Adrien Guillaume,Vojtech Stejskal,Guillaume Smits,Dorottya Kelen

DOI: https://doi.org/10.3389/fped.2024.1303772

IF: 3.569

2024-02-23

Frontiers in Pediatrics

Abstract:Neonatal encephalopathy (NE) is a complex clinical condition with diverse etiologies. Hypoxic-ischemic encephalopathy (HIE) is a major contributor to NE cases. However, distinguishing NE subtypes, such as pontocerebellar hypoplasia type 1E (PCH1E), from HIE can be challenging due to overlapping clinical features. Here, we present a case of PCH1E in a neonate with a homozygous mutation c.72delT p. (Phe24LeufsTer20) in the SLC25A46 gene. The severity of PCH1E associated NE highlighted the significance of early recognition to guide appropriate clinical management.

pediatrics
Alternating Hemiplegia and Epilepsia Partialis Continua: A new phenotype for a novel compound TBC1D24 mutation

Francesca Ragona,Barbara Castellotti,Barbara Salis,Stefania Magri,Jacopo C DiFrancesco,Nardo Nardocci,Silvana Franceschetti,Cinzia Gellera,Tiziana Granata

DOI: https://doi.org/10.1016/j.seizure.2017.03.003

IF: 3.414

Seizure

Abstract:Mutations in the TBC1D24 gene (MIM 613577) cause familial infantile myoclonic epilepsy (FIME; 605021) and early infantile epileptic encephalopathy-16 (EIEE16; 615338), both inherited with an autosomal recessive trait. The TBC1D24 gene encodes a member of the TBC family domain proteins, involved in cell signaling and oxidative stress resistance. We studied, by a Next Generation Sequencing (NGS) target re-sequencing gene approach, the DNA of a 5 year-old girl, affected by recurrent attacks of Alternating Hemiplegia (AH) and by recurrent episodes of Epilepsia Partialis Continua (EPC). The NGS study showed the presence of two different heterozygous, probably pathogenic variants in the TBC1D24 gene, inherited in trans from her parents: the c.116C>T (p.Ala39Val) and the c.457G>A (p.Glu153Lys). This study describes for the first time the association between TBC1D24 variants and AH expanding the phenotypic spectrum of TBC1D24-related diseases and suggesting that TBC1D24 molecular analysis should be considered in the diagnostic work up of AH patients. An additional peculiar feature is the association of AH and EPC.
A novel frameshift variant in LAMP2 gene mimicking choroideremia carrier retinopathy

Akshay Narayan,Laura J. Taylor,Sian Sperring,Morag Shanks,Penny Clouston,Robert E. MacLaren,Jasmina Cehajic-Kapetanovic

DOI: https://doi.org/10.1080/13816810.2024.2404148

2024-09-21

Ophthalmic Genetics

Abstract:Background Danon disease is a rare, multisystemic X-linked dominant disorder caused by variants in the LAMP2 gene. It can be associated with retinal degeneration, but this is not well characterized. Here we describe a late presentation of a mild retinal phenotype, initially diagnosed as choroideremia carrier, associated with a novel variant in the LAMP2 gene.

ophthalmology,genetics & heredity
Clinical, Neuroimaging, and Metabolic Footprint of the Neurodevelopmental Disorder Caused by Monoallelic HK1 Variants

Saskia B Wortmann,Rene G Feichtinger,Lucia Abela,Loes A van Gemert,Mélodie Aubart,Claire-Marine Dufeu-Berat,Nathalie Boddaert,Rene de Coo,Lara Stühn,Jasmijn Hebbink,Wolfram Heinritz,Julia Hildebrandt,Nastassja Himmelreich,Christoph Korenke,Anna Lehman,Thomas Leyland,Christine Makowski,Rafael Jenaro Martinez Marin,Pauline Marzin,Chris Mühlhausen,Marlène Rio,Agnes Rotig,Charles-Joris Roux,Manuel Schiff,Tobias B Haack,Steffen Syrbe,Stas A Zylicz,Christian Thiel,Maria Veiga da Cunha,Emile van Schaftingen,Matias Wagner,Johannes A Mayr,Ron A Wevers,Eugen Boltshauser,Michel A Willemsen

DOI: https://doi.org/10.1212/NXG.0000000000200146

2024-04-05

Abstract:Background and objectives: Hexokinase 1 (encoded by HK1) catalyzes the first step of glycolysis, the adenosine triphosphate-dependent phosphorylation of glucose to glucose-6-phosphate. Monoallelic HK1 variants causing a neurodevelopmental disorder (NDD) have been reported in 12 individuals. Methods: We investigated clinical phenotypes, brain MRIs, and the CSF of 15 previously unpublished individuals with monoallelic HK1 variants and an NDD phenotype. Results: All individuals had recurrent variants likely causing gain-of-function, representing mutational hot spots. Eight individuals (c.1370C>T) had a developmental and epileptic encephalopathy with infantile onset and virtually no development. Of the other 7 individuals (n = 6: c.1334C>T; n = 1: c.1240G>A), 3 adults showed a biphasic course of disease with a mild static encephalopathy since early childhood and an unanticipated progressive deterioration with, e.g., movement disorder, psychiatric disease, and stroke-like episodes, epilepsy, starting in adulthood. Individuals who clinically presented in the first months of life had (near)-normal initial neuroimaging and severe cerebral atrophy during follow-up. In older children and adults, we noted progressive involvement of basal ganglia including Leigh-like MRI patterns and cerebellar atrophy, with remarkable intraindividual variability. The CSF glucose and the CSF/blood glucose ratio were below the 5th percentile of normal in almost all CSF samples, while blood glucose was unremarkable. This biomarker profile resembles glucose transporter type 1 deficiency syndrome; however, in HK1-related NDD, CSF lactate was significantly increased in all patients resulting in a substantially different biomarker profile. Discussion: Genotype-phenotype correlations appear to exist for HK1 variants and can aid in counseling. A CSF biomarker profile with low glucose, low CSF/blood glucose, and high CSF lactate may point toward monoallelic HK1 variants causing an NDD. This can help in variant interpretation and may aid in understanding the pathomechanism. We hypothesize that progressive intoxication and/or ongoing energy deficiency lead to the clinical phenotypes and progressive neuroimaging findings.
Kabuki Syndrome and Charcot-Marie-Tooth Disease Co-Occurrence: Unique Case with Novel Variant

Ahmet Kablan,Esma Erturkmen Aru

DOI: https://doi.org/10.1159/000540207

2024-07-29

Molecular Syndromology

Abstract:Introduction: Kabuki syndrome (KS) is a rare syndrome, characterized by dysmorphic features, congenital abnormalities, and developmental problems. The primary genetic causes are variants in the KMT2D and KDM6A genes. There are few KS patients with KDM6A variants, especially in Turkey. Charcot-Marie-Tooth (CMT) disease, with various subtypes, is the most common inherited peripheral neuropathy. Case Presentation: We present a case of a 7-year-old girl with characteristic dysmorphic features, neonatal hypotonia, developmental delay, and short stature. Exome sequencing revealed a novel heterozygous variant in KDM6A , along with a concurrent suspected diagnosis of CMT disease with CNV analysis, not previously reported in the literature. PMP22 duplication was later confirmed in the patient and symptomatic mother with MLPA test. Conclusion: We report a unique case of dual diagnosis with a novel de novo heterozygous variant in KDM6A and PMP22 duplication in the same patient, highlighting the additive use of exome sequencing for CNVs and, moreover, unraveling the complexity of rare diseases, particularly when multiple conditions coexist.

genetics & heredity

HK1 haemolytic anaemia in association with a neurological phenotype and co-existing CEP290 Meckel-Gruber in a Romani family

De novo variants in HK1 associated with neurodevelopmental abnormalities and visual impairment

Novel KRIT1/CCM1 and MGC4607/CCM2 Gene Variants in Chinese Families with Cerebral Cavernous Malformations

Molecular characterization of six new cases of red blood cell hexokinase deficiency yields four novel mutations in HK1

De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias (vol 103, Pg 666, 2018)

Persistent Hyperplastic Primary Vitreous with Microphthalmia and Coloboma in a Patient with Okur-Chung Neurodevelopmental Syndrome

The neurological core features of the infantile‐onset multisystem neurologic, endocrine, and pancreatic disease: A novel nonsense mutation in an Italian family

Identification of Pathogenic Variants in RPGRIP1L with Meckel Syndrome and Preimplantation Genetic Testing in a Chinese Family

Novel and recurrent PHGDH and PSAT1 mutations in Chinese patients with Neu-Laxova syndrome

Case Report: A rare form of congenital erythrocytosis due to SLC30A10 biallelic variants—differential diagnosis and recommendation for biochemical and genetic screening

Refractory and Fatal Presentation of Severe Autoimmune Hemolytic Anemia in a Child With the DNASE1L3 Mutation Complicated With an Additional DOCK8 Variant

Two novel variants in CEP152 caused Seckel syndrome 5 in a Chinese family

Molecularly confirmed pontocerebellar hypoplasia in a large family from Slovakia with four severely affected children

Comprehensive analysis of Novel mutations in CCM1/KRIT1 and CCM2/MGC4607 and their clinical implications in Cerebral Cavernous malformations

Frameshift mutations at the C-terminus of HIST1H1E result in a specific DNA hypomethylation signature

Patient with a heterozygous pathogenic variant in CSNK2A1 gene: A new case to update the Okur–Chung neurodevelopmental syndrome

A novel homozygous variant in SLC25A46 gene associated with pontocerebellar hypoplasia type 1E: a case report

Alternating Hemiplegia and Epilepsia Partialis Continua: A new phenotype for a novel compound TBC1D24 mutation

A novel frameshift variant in LAMP2 gene mimicking choroideremia carrier retinopathy

Clinical, Neuroimaging, and Metabolic Footprint of the Neurodevelopmental Disorder Caused by Monoallelic HK1 Variants

Kabuki Syndrome and Charcot-Marie-Tooth Disease Co-Occurrence: Unique Case with Novel Variant